immunity News and Research

RSS

What’s missing in the coronavirus response

In the age of coronavirus, Americans are being told to stay home and wear masks outside. The federal government has made way for hospitals to treat patients in repurposed hotels and dormitories. Private companies are working to push out new diagnostic tests.

9 Apr 2020

PIV5-based MERS vaccine shows promise for COVID-19

The coronavirus disease (COVID-19) has spread to 184 countries and territories. Currently, there is no vaccine available for COVID-19 disease, or SARS-CoV-2 infection. However, scientists around the world are racing to find ways to block the virus.

8 Apr 2020

Philadelphia Eagles owner contributes $1 million to Penn Medicine to fight COVID-19 pandemic

Philadelphia Eagles owner Jeffrey Lurie today announced a $1 million contribution to Penn Medicine to establish the COVID-19 Immunology Defense Fund, laying the foundation for the world's foremost experts to fight the novel coronavirus pandemic.

8 Apr 2020

Combining Improved Ion Usage Efficiency with Data Independent Acquisition to Quantify Proteomes

In this interview, Dr. Ben Collins, Reader from the School of Biological Sciences, Queen’s University Belfast talks to News-Medical Life Sciences about his research and work into diaPASEF workflow.

From Bruker Daltonics 8 Apr 2020

What we know about COVID-19 in children

A new viewpoint article published in the journal JAMA Pediatrics in April 2020 discusses the manifestation and management of the novel coronavirus disease devastating several countries.

7 Apr 2020

A special diet can help in certain cases of asthma, study suggests

Can a special diet help in certain cases of asthma? A new study at the University of Bonn at least points to this conclusion. According to the study, mice that were switched to a so-called ketogenic diet showed significantly reduced inflammation of the respiratory tract.

7 Apr 2020

Study: One-third of younger people in São José do Rio Preto lack antibodies against measles

In São José do Rio Preto, state of São Paulo (Brazil), almost a third of the population aged 10-40 are estimated to have no antibodies against measles, according to a new study that tested 981 people in various age groups.

7 Apr 2020

Antiparasitic drug Ivermectin kills coronavirus in 48 hours

Around the world, scientists race to develop a vaccine or treatment against the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Now, a team of researchers has found that a drug already available around the world can kill the coronavirus in a lab setting in just 48 hours.

6 Apr 2020

UC San Diego Health expands COVID-19 testing capacity

From the beginning, the ability of front line clinicians to test patients for COVID-19 -- to determine whether a person is infected with the disease-causing novel coronavirus, SARS-CoV-2 -- has been part and parcel of the pandemic.

6 Apr 2020

Virological findings from Germany's first group of COVID-19 patients

In early February, research teams from Charité - Universitätsmedizin Berlin, München Klinik Schwabing and the Bundeswehr Institute of Microbiology published initial findings describing the efficient transmission of SARS-CoV-2.

3 Apr 2020

Australian scientists identify possible coronavirus drug

A collaborative study led by Monash University's Biomedicine Discovery Institute in Melbourne, Australia, with the Peter Doherty Institute of Infection and Immunity, has shown that an anti-parasitic drug already available around the world kills the virus within 48 hours.

3 Apr 2020

Francis Crick Institute and UCLH play vital role in national COVID-19 testing effort

NHS staff testing for COVID-19 has been boosted by repurposing the Francis Crick Institute’s laboratory facilities as a testing facility, to help combat the spread of infection and allow key workers to perform lifesaving duties and remain safe.

3 Apr 2020

St George's, University of London focuses entire research on tackling coronavirus

St George's, University of London, the UK's specialist health university, is focusing all its ongoing research on tackling coronavirus.

3 Apr 2020

Strategies to manage socio-economic costs of COVID-19 pandemic

The governmental decision on when to loosen social distancing measures should not only depend on the latest number of cases.

3 Apr 2020

New molecular mechanism that regulates the sentinel cells of the immune system

A study suggests that it may be possible to regulate macrophages with drugs that modulate the nuclear receptor RXR.

3 Apr 2020

Promising vaccine patch candidate for COVID-19

In a breath of fresh air, scientists from the University of Pittsburgh School of Medicine reported that they had developed a potential new vaccine against the SARS-CoV-2 virus, which is causing the current COVID-19 pandemic. The vaccine has been tested in mice. When administered through a small patch only the size of a fingertip, the vaccine was found to generate protective neutralizing antibodies against the virus, in adequate quantities.

2 Apr 2020

Nanoneedle technology licensed for early detection of disease, biomarker discovery

A Boston-based startup company, NanoMosaic LLC, intends to commercialize a high-throughput, high-sensitivity platform for analyte detection developed at Harvard University.

2 Apr 2020

OXGENE and The Native Antigen Company Announce Collaboration to Increase COVID-19 Antigen Production for Diagnostic Kits and Vaccine Development

OXGENE™ and The Native Antigen Company today announced a collaboration to scale up production of SARS-CoV-2 (COVID-19) reagents.

2 Apr 2020

What are coronaviruses and COVID-19?

The current COVID-19 pandemic is caused by a novel coronavirus called SARS-CoV-2, or severe acute respiratory syndrome coronavirus 2. Coronavirus disease 2019 (COVID-19) is an infectious disease caused by SARS-CoV-2.

1 Apr 2020

Putting an end to the pandemic

From the plagues of medieval Europe to the influenza pandemic of 1918, the specter of the next public health disaster has gripped the minds of scientists, captivated the imaginations of writers and vexed conspiracy theorists.

1 Apr 2020

immunity News and Research

What’s missing in the coronavirus response

PIV5-based MERS vaccine shows promise for COVID-19

Philadelphia Eagles owner contributes $1 million to Penn Medicine to fight COVID-19 pandemic

Combining Improved Ion Usage Efficiency with Data Independent Acquisition to Quantify Proteomes

What we know about COVID-19 in children

A special diet can help in certain cases of asthma, study suggests

Study: One-third of younger people in São José do Rio Preto lack antibodies against measles

Antiparasitic drug Ivermectin kills coronavirus in 48 hours

UC San Diego Health expands COVID-19 testing capacity

Virological findings from Germany's first group of COVID-19 patients

Australian scientists identify possible coronavirus drug

Francis Crick Institute and UCLH play vital role in national COVID-19 testing effort

St George's, University of London focuses entire research on tackling coronavirus

Strategies to manage socio-economic costs of COVID-19 pandemic

New molecular mechanism that regulates the sentinel cells of the immune system

Promising vaccine patch candidate for COVID-19

Nanoneedle technology licensed for early detection of disease, biomarker discovery

OXGENE and The Native Antigen Company Announce Collaboration to Increase COVID-19 Antigen Production for Diagnostic Kits and Vaccine Development

What are coronaviruses and COVID-19?

Putting an end to the pandemic

Industry Focus eBook - Cell biology (5th edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News